A sandwich enzyme linked immunosorbent assay (ELISA) for apolipoprotein C-III was developed. Anti apolipoprotein C-III immunoglobulins were used both for coating of microtitre plates and for the preparation of an anti apolipoprotein C-III horse-radish peroxidase conjugate.
Introduction
The C-and E apolipoproteins play an important TT (3, 4) and might also prevent the hepatic uptake of functions of the apolipoproteins has stressed the ^ . , . .T ,. , . /c f , . * * . ' . . , ~\ triglycende-nch hpoprotems (5, 6) . importance of their quantification in plasma (l, 2). Most studies have focused on the major apo-Immunological assays have been developed mainly lipoproteins of HDL (apojipoproteins A-I and A-II) for the apolipoproteins A-I, A-II and B proteins and LDL (apolipoprotein B).
by a variety of techniques (7, 8) . Quantitation of apolipoprotcin C-III by radioimmunoassay (RIA) (9, 10) , clcctroimmunodiffusion (EID) (l 1), a competitive enzyme linked immunosorbent assay (ELISA) (12) and an immunonephelometric assay (INA) (13) have been previously reported.
This report describes the technical optimization and the validation of a Sandwich enzyme linked immunosorbent assay (ELISA), which was developed for the measurement of human apolipoprotein C-III in plasma and in lipoprotein fractions. Results are evaluated by comparison with other techniques, described previously.
Material and Methods

Isolation of apuliprotcins and production of antisera
The thrce apolipoprotcin C-III isoforras (i.e. apolipoproteins C-111 0 , C-III, and C-HI 2 ) were isolated from human apolipoprotcins of Vcry Low Density Lipoproteins by a combination of gcl Filtration on a Sephacryl S 200 column and ionexchangc chromatography on a DEAE-cellulose column, s described previously (13) . The homogeneity of the apolipoprotein C-III preparation, used s primary Standard and immunogcn, was checked by electrophoresis on polyacrylamide gcls, containing cither 8 mol/1 urca (14) or l g/l sodium dodecyl sulphate (15) , by immunodiffusion with antisera against apolipoprotein A-I, A-II, B, C-III, E and albumin, and by amino acid analysis, based on the composition of purified apolipoprotein C-III (16).
Apolipoprotein A-I and apolipoprotein A-II were purified from apo High Density Lipoproteins by ion exchange chromatography (17, 18) . Watcr soluble apolipoprotein B was prepared from Low Density Lipoproteins (d = 1.030-1.050 kg/l) s described by Cardin et al. (19) and apolipoprotein E were isolated from apolipoproteins of Very Low Density Lipoproteins by high performance liquid chromatography using an UltroPak TSK-G 3000 SW column (LKB, Broma, Sweden) (20, 21) .
The antiscra to these purified apolipoproteins were raised in rabbits s prcviously described (13, 18, 22, 23) .
Preparation of the coater and the enzyme-antibody conjugate
An apolipoprotein C-III affmity column was prepared by covalent linkage of 8 mg apolipoprotein C-III to l g CNBractivated Sepharosc 4 B (Pharmacia, Uppsala, Sweden) (24) . Anti human apolipoprotein C-III immunoglobulins were isolated from a rabbit antiserum by affmity chromatography, according to the Standard procedure, and were used both for coating and for the preparation of an enzyme-antibody conjugate. For this purpose 2 mg of horse-radish peroxidase was covalently linked to 4mg purified anti-apolipoprotein C-III immunoglobulin by the periodate coupling procedure described by Nakane (25) .
The immunoglobulins, used for coating, were stored at 4°C in 0.05 mol/1 sodium borate, 0.15 mol/1 NaCl, containing l g/i NaN 3 , whilc the antibody-enzyme conjugate was stored in aliquots at -20°C, mixed with an equal volume of glycerol (26) . This preparation was stable for at least six months, without any loss of activity.
Buffer System
A sodium phosphate buffer 10mmol/l pH 7.4, containing 0.15 mol/1 NaCl was used throughout the whole procedure for coating, incubations and washings. In addition the coating buffer contained l g/l NaN 3 , whereas the assay buffer containcd 10 g/l bovine serum albumin (27) . To reduce non-specific binding, the wash buffer contained 0.5 ml/l Tween 20 (26) .
Coating of the solid phase
Purified anti-apolipoprotein C-III immunoglobulins (ΙΙΟμΙ) at a concentration of 25 mg/1 were pipetted' into each well of a polystyrene microtitre plate (Fiat Bottom micro ELISA plates, 129 B, Dynatech Lab Inc., Alexandria, Virginia, 22314), excluding the outer rows which tend to produce edge effects (28) . The plates were sealed (Sealing tape, Dynatech), and incubated for 3 h at 37°C before an overnight incubation at 4°C. The plates were used either immediately or stored with the coater at 4°C for a maximum of two weeks. Before use the plates were washed three times with wash buffer and incubated one hour at room temperature with the assay buffer, in order to block any residual coupling sites with albumin (29) . The plates were subsequently washed three times and shaken dry.
Apolipoprotein C-III quantitation by Sandwich ELISA
Standard or plasma samples (ΙΟΟμΙ), representing 5000-fold dilutions (Microlab 1000 dilutor, Hamilton, Bonaduz, Switzerland), were pipetted into the wells of a precoated microtitre plate. The plates were covered and incubated at 37°C for 2 h. The content of each well was aspirated and the plates were washed five times. After 10000 dilution with assay buffer, the affmity purified anti-apolipoprotein OIII peroxidase conjugate (100 μΐ) was added to each well and plates were incubated for 2 h at 37 °C. The wells were subsequently emptied and washed five times. The o-phenylenediamine hydrochloride Substrate (Sigma chemical Co, St. Louis, MO 63178), at a concentration of 3 g/l, was freshly prepared in a 0.01 mol/1 sodium-phosphatecitr te buffer pH 5.6, containing 0.2 g/l H 2 O 2 . An aliquot of this solution (ΙΟΟμΙ) was pipetted into each well at timed intervals and left at roora temperature in the dark. After 30 min the reaction was blocked by adding 100 μΐ of 2.5 mol/1 sulphuric acid (Analytical Grade, Merck, Darmstadt, FRG). The developed colour was read within two hours on a Chfomo Scan EIA Reader (Bio-Tech Instrument, Burlington, VT 05401) at 490 nm. Calibration curves were obtained frorh the appropriate dilutions of purified apolipoprotein QIII 2 , whose concentration was assessed by amino acid analysis. This primary Standard was solubilized in the sodium phosphate buffer, containing the nonionic detergent Apovax (Ortho Diagnostics, Beerse, Belgium) at a concentration of 0.1 g/l, then further diluted with the ELISA assay-buffer. Sera from normolipidaeinic donors, aliquoted and stored at -20°C, were used s a suitable secondary Standard and control (7, 8) . Standard curves were obtained by plotting the absorbance at 490 nm s function of the logarithm of the apolipoprotein C-III concentration.
Apolipoprotein C-III distribution in lipoprotein fractions
Lipoproteins were separated from l ml fresh disodium EDTAplasma (l g/l) by gel filtration on a Sepharose 6 BCL column (1.6 χ 90cm), equilibrated with 2mmol/l Na 3 PO 4 , 0.2 mol/1 NaCl, l mmol/1 disodium EDTA and l g/l NaN 3 , pH 7.4 and eluted at 9.2 ml/h. Apolipoprotein C-III was assayed in all fractions by the ELISA procedure described above and cholesterol was assayed enzymatically (30) .
Results
Optimization of the assay conditions
Optimal coating concentration and conjugate dilution were determined by using the chequerboard titration, described by Voller et aL (26) . A good sensitivity, together with a low zero-dose response were achieved, using a coating concentration of 25 μ § purified antiapolipoprotein C-III immunoglobulins per ml coating buffer and a final antibody-peroxidase dilution of 10000 fold.
A second coating with albumin, to block any residual binding sites on the polystyrene plates (29) decreased the intra-assay CV by a factor two. This procedure, in combination with the use of 0.5 ml Tween 20 per l wash buffer, yielded a four-fold increase of the intraassay precision from 13.5% to 3.8%.
Standardiza on
As shown in figure l, the calibration curve constructed with purified apolipoprotein C-III2 and with the plasma obtained from a normolipidaemic subject and from a subject with a severe Fredrickson type V hyperlipoproteinaemia (triglycerides 47.25 g/l and cholesterol 8.85 g/l) were identical. Delipidation of the plasma samples (31) did not increase the apolipoprotein C-III immunoreactivity, indicating that all apolipoprotein G-III epitopes are accessible to titration in native plasma.
The calibration curves, obtained with lipoprotein fractions freshly isolated from plasma by sequential ultracentrifugation, paralleled the Standard curve constructed with purified apolipoprotein C-III 2 ( fig. 2) . Identical curves were obtained after delipidation of chylomicra, Very Low Density Lipoproteins and High Density Lipoproteins. 
Sensitivity, precision and accuracy
The enzyme linked immunosorbent assay is sensitive down to 0.3 ng apolipoprotein C-III with a working r nge of l to 6 ng apolipoprotein C-III. Using a 5000 fold dilution, this r nge corresponds to apolipoprotein C-III plasma concentrations fcetween 0.05 and 0.30 g/l. The selecüvity of the ELISA for apolipoprotein C-III was investigated by constructing calibration curves with purified apolipoproteins A-I, A-II, B, C-III 2 , E and human albumin. As shown in figure 2 , the crossreactivity of these antigens with anti-apolipoprotein C-III immunoglobulins, amounted to 1.02,0.00,0.51, 100.00, 0.56 and 0.00% respectively.
Five plasma samples, with low, intermediate and high concentrations of apolipoprotein C-III, were änalysed twenty times in the same assay and twice a week during five weeks to calculate the assay precision. As shown in tablel, the average intra-and inter-assay CV amounted to 3.6% and 4.2% respeetively. In order to investigate the accuracy of the assay, apolipoprotein C-III was assayed in 79 plasma samples both by immunonephelometry (13) and by the ELISA procedure described above. The regression line between the two techniques ( fig. 3 ) has a correlation coefficient of 0.982 and is represented by the equation y = 0.988x -0.002. A paired t-test failed to detect any significant difference (p < 0.05) between the two immunoassays. elevated apolipoprotein C-III levels, whereas all other hyperlipoproteinaemic subjects had significantly higher (p < 0.001) apolipoprotein C-III vahies than normals and type Ila patients. The highest apolipoprotein C-III concentratipns were observed in Fredrickson type V hyperlipoproteinaemic patients.
Apolipoprotein C-HI concentrations in human plasma
Investigations on 76 patients with a wide ränge of total plasma triglycerides (0.27^-47.25 g/l), and total plasma cholesterol (l .02-8.85 g/l) showed that apolipoprotein C-III plasma concentrations were positively correlated with plasma triglycerides (r = 0.93) and total plasma cholesterol (r = 0.83).
Distribution of apolipoprotein lipoprotein fractions C-III among the
The apolipoprotein GJII profile was investigated in 3 normal and 3 severe Fredrickson type V subjects äs described under methods. In the normolipaemic subjects apolipoprotein C-III was distributed äs follows: 15.4 ± 0.8% (mean ± SD) in the Very Low Density Lipoproteins, 11.1 ± 0.6% in Low Density Lipoproteins and 73.5 ± 2.9% in High Density Lipoproteins. In the three Fredrickson type V patients 86.8 ± 4.9% of the apolipoprotein C-III was found in the triglyceride-rich lipoproteins (i.e. chylomicra and Very Low Density Lipoproteins) while High Density Lipoproteins cholesterol contained only 5.6 ± 1.7% apolipoprotein C-III (cf. fig. 4 ). 
Discussion
Several immunological assays have been described for the measurement of human apolipoprotein C-III (9 -13) each of which has its own characteristics and liinitations. For the electro-immunodiffusion assay (EID) the seleetion of a primary Standard with the same migration properties äs the unknown sample is critical. The major limitation of laser nephelometric assays is the sample turbidity. This is caused by the presence of triglyceride-rich lipoproteins, and necessitates sample delipidation prior to the assay (13) . Radioimmunoassay is the most sensitive technique: down to 0.8 ng apolipoprotein C-III (10). However, it suffers from various major drawbacks, including expensive counting equipment, unstable reagents and biohazards, associated with the handling of radioisotopes. These disadvantages can easily be circumvented by replacing the isotope label by an enzyme.
For this purpose a non-competitive enzyme linked immunosorbent assay was developed for the measurement of apolipoprotein C-III. The Sandwich type assay was selected, äs both coater and conjugate can be prepared from immunoglobulins with a high stability i. e.: the anti-apolipoprotein C-III-peroxidase conjugate was stable for at least 6 months, without loss of activity.
Standard curves, constructed either with plasma äs a secondary Standard or with lipoprotein fractions, paralleled the calibration curves, constructed with purified apolipoprotein C-III, which served äs the primary Standard. In contrast with the electroiminunoassay described by Curry et al. (11) , the apolipoprotein C-III immunoreactivity was not enhanced by delipidation. Therefore, the ELISA assay does not detect any difference in the exposure of the apolipoprotein C-III epitopes, on the free or on the lipid-boünd protein.
Compared with previously described techniques (CV: 6 -13%), the use of affinity purified antibodies yielded a high assay sensitivity (0.3 ng apolipoprotein C-) and Standard curves with a steep slope, together with a high assay precision (CV: 4%).
The ELISA assay was evaluated by comparison with an immunonephelometric assay for apolipoprotein C-III, yielding a correlation coefficient of 0.982 (n = 79). Plasma apolipoprotein C-III and triglyceride concentrations were well correlated (r = 0.93, n = 76) äs shown by a 3-fold increase of apolipoprotein C-III levels in patients with hypertriglyceridaemia (Fredrickson types I, II b and IV), and by a 5 to 10-fold increase in patients with a Fredrickson type V hyperlipoproteinaemia äs compared to normolipidaemic subjects.
Apolipoprotein C-III, which plays an important role in triglyceride catabolism, is distributed among triglyceride-rich lipoproteins and HDL. This distribution can easily be influenced by both endogeneous and exogeneous factors (32) . Due to its sensitivity and precision this ELISA assay is especially suited to the study of apolipoprotein C-III profiles after plasma lipoprotein Separation by either column chromatography or gradient ultracentrifugation. This was demonstrated on normolipaemic and hypertriglyceridaemic plasma samples separated on a Sepharose 6 B column. In agreement with previous reports (9, (11) (12) (13) , the hypertriglyceridaemic state is attented by a higher amount of apolipoprotein C-III in the triglyceride-rich lipoprotein fractions, suggesting that the apolipoprotein C-III profile could become a useful marker of triglyceride metabolism.
The characterization of the apolipoprotein C-III content and distribution in plasma should provide a better insight in to the function of this apolipoprotein in lipoprotein metabolism.
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